ReviewBiomedicines2022
Adrenomedullin Therapy in Moderate to Severe COVID-19.
Toshihiro Kita et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled ittrialcites it
ReviewBiomedicines2022
Toshihiro Kita et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.